ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NTHI vs NRXP // REVENUE GROWTH (YOY)

NeOnc Technologies Holdings Inc. (NASDAQ) VS. NRX Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: NTHI 1 — NRXP 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTHI VS. NRXP) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NTHI NRXP SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 58.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -21.93% -12.25% -9.68 NRXP /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE -51.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 2/9 -1.00 NRXP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.6 30.0 +19.60 NTHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $91.4M $94.0M -$2.6M NRXP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NTHI REV NRXP REV NTHI GROSS % NRXP GROSS % NTHI FCF NRXP FCF
FY 2025 $40.0K $1.2M — 58.8% -$20.4M -$14.1M
FY 2024 $83.0K $51.8M — — -$4.2M -$10.6M
FY 2023 — $77.9M — — — -$21.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTHI // BETA —
NRXP // BETA —